Bionime Corporation

TWSE:4737.TW

70.3 (TWD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income -31.87586.48374.58531.111134.567161.963188.802213.931123.22985.886124.07834.147179.111136.05135.237
Depreciation & Amortization 163.422153.232154.657163.482164.485151.335145.797158.014153.347147.544105.343100.08871.78144.14129.509
Deferred Income Tax -81.5450-28.302-9.338-25.87-28.869-14.0230-62.941-88.949-19.3931.0271.2200
Stock Based Compensation 4.7817.85212.77315.53513.69720.63315.14702.28912.56516.81915.0784.34700
Change In Working Capital 104.745-138.49637.665-3.2785.205-210.516-327.05562.831-71.79140.357-118.776-157.509-54.284-179.5538.023
Accounts Receivables 208.744-350.94196.31274.3276.279-223.039-196.462-75.403-15-15.004-7.204-14.732000
Inventory 47.17549.772-71.552-125.18316.064-49.953-53.52536.621-20.302-16.449-20.827.835-175.928-50.41-37.406
Accounts Payables -31.50828.064.817-2.72-13.79218.029-43.92859.495-40.911000000
Other Working Capital -119.666134.6138.09-149.6876.654-160.563-273.5326.21-51.488156.806-97.956-165.344121.644-129.1475.429
Other Non Cash Items 43.91533.22118.34420.03633.47227.35220.93123.0656.23162.4420.9130.74414.75513.024.789
Operating Cash Flow 203.443142.292269.722217.556405.556121.89829.599457.836200.365359.843128.98123.575216.9313.661207.558
Investing Activities:
Investments In Property Plant And Equipment -441.397-312.921-284.569-296.395-138.072-168.766-123.059-36.796-137.331-56.946-476.562-1,008.514-1,558.157-105.456-46.123
Acquisitions Net -1.014.734033.621-49.5777.986000.545000000
Purchases Of Investments 5.996-3.563-3.775-33.621-6-6.7157.62-380.042-19.958000000
Sales Maturities Of Investments 5.996-4.7340-33.62116.159273.692000000000
Other Investing Activites -4.8464.2280.274-0.75248.45.475-0.2881.889-2.1571.3762.075-36.61-9.826-1.30416.834
Investing Cash Flow -435.261-312.256-288.07-330.768-129.09110.401-65.727-414.949-159.446-55.57-474.487-1,045.124-1,567.983-106.76-29.289
Financing Activities:
Debt Repayment -374.507-3,126.408-39.9-2,507.082-2,128.399-2,049.142-1,634.229-641.854-5,031.595-331.2-1,1000000
Common Stock Issued 10.4649.31930.56267.97252.05302,360.96601,140283.002000364.322.226
Common Stock Repurchased 0002,653.7151,851.220-423.71703,845.959000000
Dividends Paid -127.685-121.204-124.284-118.664-114.894-237.83-241.098-126.894-48.36-78.225-35.157-158.209-119.855-115.954-8.365
Other Financing Activities 173.5833,351.92815.0870.3931.9982,307.518-423.717507.3630.15301.6131,904.106996.1361,393.54300
Financing Cash Flow 420.405113.635-69.29796.334-338.02220.546-361.795-261.385-93.846-107.812768.949837.9271,273.688248.366-6.139
Other Information:
Effect Of Forex Changes On Cash -11.25517.733-2.5170.567-12.5176.438-16.606-8.93.6966.7786.903-6.6447.502-10.824-1.943
Net Change In Cash 177.332-38.596-90.162-16.311-74.073259.283-414.529-227.398-49.231203.239430.346-190.266-69.863144.443170.187
Cash At End Of Period 391.821214.489253.085343.247359.558433.631174.348588.877816.275865.506662.267231.921422.187492.05347.607